19th March 2024 (13 Topics)
1
Mar
2
Mar
4
Mar
5
Mar
6
Mar
7
Mar
8
Mar
9
Mar
11
Mar
12
Mar
13
Mar
14
Mar
15
Mar
16
Mar
18
Mar
19
Mar
20
Mar
21
Mar
22
Mar
23
Mar
25
Mar
26
Mar
27
Mar
28
Mar
29
Mar
30
Mar
Dengue Vaccine
Context
Indian Immunologicals Limited, a wholly owned subsidiary of the National Dairy Development Board has finished the first phase of clinical trials of dengue vaccine to determine the safety of the vaccine. The vaccine could be available commercially as early as mid-2026.
About
About Dengue
- Dengue (break-bone fever) is a viral infection that spreads from mosquitoes (Aedes aegypti mosquito) to people. It is more common in tropical and subtropical climates.
- Symptoms: High fever, headache, body aches, nausea and rash.
- Treatment: There is no specific treatment for dengue. In severe cases, dengue can be fatal.
- Global burden: There are around 100–400 million infections per year and nearly half the world's population is at risk.
More Articles
Courses
Study
Notes
Home
Resources
More
